nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.0249	0.026	CcSEcCtD
Fluvoxamine—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.0246	0.0256	CcSEcCtD
Fluvoxamine—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.021	0.0219	CcSEcCtD
Fluvoxamine—Psoriasis—Ramipril—type 1 diabetes mellitus	0.0195	0.0203	CcSEcCtD
Fluvoxamine—Parosmia—Ramipril—type 1 diabetes mellitus	0.0189	0.0196	CcSEcCtD
Fluvoxamine—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0176	0.0183	CcSEcCtD
Fluvoxamine—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.0164	0.0171	CcSEcCtD
Fluvoxamine—Ageusia—Ramipril—type 1 diabetes mellitus	0.0151	0.0157	CcSEcCtD
Fluvoxamine—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.0148	0.0154	CcSEcCtD
Fluvoxamine—Cough increased—Ramipril—type 1 diabetes mellitus	0.0134	0.0139	CcSEcCtD
Fluvoxamine—Glossitis—Ramipril—type 1 diabetes mellitus	0.0133	0.0138	CcSEcCtD
Fluvoxamine—Drug interaction—Ramipril—type 1 diabetes mellitus	0.0132	0.0137	CcSEcCtD
Fluvoxamine—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.013	0.0136	CcSEcCtD
Fluvoxamine—Vasculitis—Ramipril—type 1 diabetes mellitus	0.0125	0.013	CcSEcCtD
Fluvoxamine—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.0119	0.0124	CcSEcCtD
Fluvoxamine—Neuropathy—Ramipril—type 1 diabetes mellitus	0.0115	0.012	CcSEcCtD
Fluvoxamine—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.0111	0.0116	CcSEcCtD
Fluvoxamine—Urine output increased—Ramipril—type 1 diabetes mellitus	0.0111	0.0115	CcSEcCtD
Fluvoxamine—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.0103	0.0107	CcSEcCtD
Fluvoxamine—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.0101	0.0105	CcSEcCtD
Fluvoxamine—Polyuria—Ramipril—type 1 diabetes mellitus	0.0101	0.0105	CcSEcCtD
Fluvoxamine—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.01	0.0104	CcSEcCtD
Fluvoxamine—Deafness—Ramipril—type 1 diabetes mellitus	0.00993	0.0103	CcSEcCtD
Fluvoxamine—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00993	0.0103	CcSEcCtD
Fluvoxamine—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00962	0.01	CcSEcCtD
Fluvoxamine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00957	0.00997	CcSEcCtD
Fluvoxamine—Amnesia—Ramipril—type 1 diabetes mellitus	0.00945	0.00984	CcSEcCtD
Fluvoxamine—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00941	0.0098	CcSEcCtD
Fluvoxamine—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00933	0.00971	CcSEcCtD
Fluvoxamine—Purpura—Ramipril—type 1 diabetes mellitus	0.00921	0.00959	CcSEcCtD
Fluvoxamine—Arthritis—Ramipril—type 1 diabetes mellitus	0.00914	0.00951	CcSEcCtD
Fluvoxamine—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.0091	0.00947	CcSEcCtD
Fluvoxamine—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.0091	0.00947	CcSEcCtD
Fluvoxamine—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00906	0.00943	CcSEcCtD
Fluvoxamine—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00891	0.00928	CcSEcCtD
Fluvoxamine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00881	0.00917	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.0082	0.00853	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00811	0.00844	CcSEcCtD
Fluvoxamine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00802	0.00835	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.008	0.00832	CcSEcCtD
Fluvoxamine—Gastritis—Ramipril—type 1 diabetes mellitus	0.00786	0.00818	CcSEcCtD
Fluvoxamine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00767	0.00799	CcSEcCtD
Fluvoxamine—Asthma—Ramipril—type 1 diabetes mellitus	0.00767	0.00799	CcSEcCtD
Fluvoxamine—Influenza—Ramipril—type 1 diabetes mellitus	0.00767	0.00799	CcSEcCtD
Fluvoxamine—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00752	0.00783	CcSEcCtD
Fluvoxamine—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00748	0.00778	CcSEcCtD
Fluvoxamine—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00748	0.00778	CcSEcCtD
Fluvoxamine—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00738	0.00768	CcSEcCtD
Fluvoxamine—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00736	0.00766	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00713	0.00743	CcSEcCtD
Fluvoxamine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00707	0.00736	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.007	0.00729	CcSEcCtD
Fluvoxamine—Weight increased—Ramipril—type 1 diabetes mellitus	0.00698	0.00727	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00678	0.00706	CcSEcCtD
Fluvoxamine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00675	0.00702	CcSEcCtD
Fluvoxamine—Renal failure—Ramipril—type 1 diabetes mellitus	0.00673	0.007	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00671	0.00698	CcSEcCtD
Fluvoxamine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00671	0.00698	CcSEcCtD
Fluvoxamine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00667	0.00694	CcSEcCtD
Fluvoxamine—Jaundice—Ramipril—type 1 diabetes mellitus	0.00667	0.00694	CcSEcCtD
Fluvoxamine—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00665	0.00692	CcSEcCtD
Fluvoxamine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00665	0.00692	CcSEcCtD
Fluvoxamine—Sweating—Ramipril—type 1 diabetes mellitus	0.00656	0.00683	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00647	0.00674	CcSEcCtD
Fluvoxamine—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00645	0.00672	CcSEcCtD
Fluvoxamine—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00642	0.00668	CcSEcCtD
Fluvoxamine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00639	0.00665	CcSEcCtD
Fluvoxamine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00614	0.00639	CcSEcCtD
Fluvoxamine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00605	0.0063	CcSEcCtD
Fluvoxamine—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00592	0.00616	CcSEcCtD
Fluvoxamine—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00581	0.00605	CcSEcCtD
Fluvoxamine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00573	0.00596	CcSEcCtD
Fluvoxamine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00549	0.00571	CcSEcCtD
Fluvoxamine—Alopecia—Ramipril—type 1 diabetes mellitus	0.00543	0.00565	CcSEcCtD
Fluvoxamine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00538	0.0056	CcSEcCtD
Fluvoxamine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00535	0.00557	CcSEcCtD
Fluvoxamine—Tension—Ramipril—type 1 diabetes mellitus	0.00525	0.00546	CcSEcCtD
Fluvoxamine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00524	0.00545	CcSEcCtD
Fluvoxamine—Nervousness—Ramipril—type 1 diabetes mellitus	0.00519	0.00541	CcSEcCtD
Fluvoxamine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00514	0.00535	CcSEcCtD
Fluvoxamine—Tremor—Ramipril—type 1 diabetes mellitus	0.00501	0.00522	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00496	0.00517	CcSEcCtD
Fluvoxamine—Agitation—Ramipril—type 1 diabetes mellitus	0.00491	0.00512	CcSEcCtD
Fluvoxamine—Angioedema—Ramipril—type 1 diabetes mellitus	0.00489	0.00509	CcSEcCtD
Fluvoxamine—Malaise—Ramipril—type 1 diabetes mellitus	0.00482	0.00502	CcSEcCtD
Fluvoxamine—Vertigo—Ramipril—type 1 diabetes mellitus	0.0048	0.005	CcSEcCtD
Fluvoxamine—Syncope—Ramipril—type 1 diabetes mellitus	0.0048	0.00499	CcSEcCtD
Fluvoxamine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00479	0.00498	CcSEcCtD
Fluvoxamine—Palpitations—Ramipril—type 1 diabetes mellitus	0.00473	0.00492	CcSEcCtD
Fluvoxamine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.0047	0.00489	CcSEcCtD
Fluvoxamine—Cough—Ramipril—type 1 diabetes mellitus	0.00467	0.00486	CcSEcCtD
Fluvoxamine—Convulsion—Ramipril—type 1 diabetes mellitus	0.00463	0.00482	CcSEcCtD
Fluvoxamine—Chest pain—Ramipril—type 1 diabetes mellitus	0.00455	0.00474	CcSEcCtD
Fluvoxamine—Myalgia—Ramipril—type 1 diabetes mellitus	0.00455	0.00474	CcSEcCtD
Fluvoxamine—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00455	0.00474	CcSEcCtD
Fluvoxamine—Anxiety—Ramipril—type 1 diabetes mellitus	0.00454	0.00472	CcSEcCtD
Fluvoxamine—Discomfort—Ramipril—type 1 diabetes mellitus	0.0045	0.00468	CcSEcCtD
Fluvoxamine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00445	0.00464	CcSEcCtD
Fluvoxamine—Confusional state—Ramipril—type 1 diabetes mellitus	0.0044	0.00458	CcSEcCtD
Fluvoxamine—Oedema—Ramipril—type 1 diabetes mellitus	0.00436	0.00454	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00436	0.00454	CcSEcCtD
Fluvoxamine—Shock—Ramipril—type 1 diabetes mellitus	0.00429	0.00447	CcSEcCtD
Fluvoxamine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00428	0.00446	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00427	0.00445	CcSEcCtD
Fluvoxamine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00426	0.00443	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00422	0.00439	CcSEcCtD
Fluvoxamine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00416	0.00433	CcSEcCtD
Fluvoxamine—Hypotension—Ramipril—type 1 diabetes mellitus	0.00408	0.00425	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00398	0.00414	CcSEcCtD
Fluvoxamine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00395	0.00411	CcSEcCtD
Fluvoxamine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00392	0.00408	CcSEcCtD
Fluvoxamine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00389	0.00405	CcSEcCtD
Fluvoxamine—Somnolence—Ramipril—type 1 diabetes mellitus	0.00388	0.00404	CcSEcCtD
Fluvoxamine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00384	0.004	CcSEcCtD
Fluvoxamine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00379	0.00395	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00377	0.00392	CcSEcCtD
Fluvoxamine—Fatigue—Ramipril—type 1 diabetes mellitus	0.00376	0.00392	CcSEcCtD
Fluvoxamine—Constipation—Ramipril—type 1 diabetes mellitus	0.00373	0.00389	CcSEcCtD
Fluvoxamine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.0036	0.00374	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00357	0.00372	CcSEcCtD
Fluvoxamine—Urticaria—Ramipril—type 1 diabetes mellitus	0.00347	0.00361	CcSEcCtD
Fluvoxamine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00345	0.00359	CcSEcCtD
Fluvoxamine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00345	0.00359	CcSEcCtD
Fluvoxamine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00322	0.00335	CcSEcCtD
Fluvoxamine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00313	0.00326	CcSEcCtD
Fluvoxamine—Pruritus—Ramipril—type 1 diabetes mellitus	0.00309	0.00321	CcSEcCtD
Fluvoxamine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00299	0.00311	CcSEcCtD
Fluvoxamine—Dizziness—Ramipril—type 1 diabetes mellitus	0.00289	0.003	CcSEcCtD
Fluvoxamine—Vomiting—Ramipril—type 1 diabetes mellitus	0.00277	0.00289	CcSEcCtD
Fluvoxamine—Rash—Ramipril—type 1 diabetes mellitus	0.00275	0.00286	CcSEcCtD
Fluvoxamine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00275	0.00286	CcSEcCtD
Fluvoxamine—Headache—Ramipril—type 1 diabetes mellitus	0.00273	0.00285	CcSEcCtD
Fluvoxamine—Nausea—Ramipril—type 1 diabetes mellitus	0.00259	0.0027	CcSEcCtD
Fluvoxamine—SLC6A3—Parkinsons Disease Pathway—CASP3—type 1 diabetes mellitus	0.0002	0.00507	CbGpPWpGaD
Fluvoxamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.0002	0.00506	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—ABCC8—type 1 diabetes mellitus	0.000199	0.00504	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.000199	0.00504	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—FOXP3—type 1 diabetes mellitus	0.000198	0.00501	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.000198	0.00501	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.000197	0.00498	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—GAD2—type 1 diabetes mellitus	0.000174	0.0044	CbGpPWpGaD
Fluvoxamine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000171	0.00432	CbGpPWpGaD
Fluvoxamine—SLC6A3—Monoamine Transport—TNF—type 1 diabetes mellitus	0.000167	0.00423	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.000164	0.00416	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000164	0.00414	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000162	0.00411	CbGpPWpGaD
Fluvoxamine—SLC6A3—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	0.000161	0.00408	CbGpPWpGaD
Fluvoxamine—CYP1A2—Estrogen Receptor Pathway—STAT3—type 1 diabetes mellitus	0.000157	0.00399	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000157	0.00398	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000152	0.00386	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—GAD1—type 1 diabetes mellitus	0.000151	0.00382	CbGpPWpGaD
Fluvoxamine—SLC6A3—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.000148	0.00376	CbGpPWpGaD
Fluvoxamine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.000147	0.00373	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-DPB1—type 1 diabetes mellitus	0.000144	0.00364	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-E—type 1 diabetes mellitus	0.000141	0.00358	CbGpPWpGaD
Fluvoxamine—CYP1A2—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000138	0.0035	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—CTLA4—type 1 diabetes mellitus	0.000136	0.00345	CbGpPWpGaD
Fluvoxamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000132	0.00334	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.000126	0.00319	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000123	0.00312	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.000122	0.00309	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000121	0.00307	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	0.00012	0.00305	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-DQA1—type 1 diabetes mellitus	0.00012	0.00304	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000118	0.003	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000118	0.003	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-DQB1—type 1 diabetes mellitus	0.000112	0.00284	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000112	0.00283	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.000111	0.00281	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—CD86—type 1 diabetes mellitus	0.000108	0.00274	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	0.000107	0.00272	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000107	0.00271	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.000107	0.00271	CbGpPWpGaD
Fluvoxamine—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000107	0.0027	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—CD40LG—type 1 diabetes mellitus	0.000106	0.00268	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IL10—type 1 diabetes mellitus	0.000106	0.00268	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.000105	0.00265	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.000103	0.00261	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.000102	0.00257	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000101	0.00256	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.000101	0.00255	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—FASLG—type 1 diabetes mellitus	9.85e-05	0.00249	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	9.44e-05	0.00239	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 1 diabetes mellitus	9.38e-05	0.00238	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	9.33e-05	0.00236	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—GSTT1—type 1 diabetes mellitus	9.14e-05	0.00232	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	8.53e-05	0.00216	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	8.51e-05	0.00216	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	8.49e-05	0.00215	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—GSTT1—type 1 diabetes mellitus	8.41e-05	0.00213	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	8.35e-05	0.00212	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	8.34e-05	0.00211	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	8.19e-05	0.00207	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	8.17e-05	0.00207	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	8.17e-05	0.00207	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—CD80—type 1 diabetes mellitus	7.88e-05	0.002	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	7.78e-05	0.00197	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	7.78e-05	0.00197	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	7.66e-05	0.00194	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	7.53e-05	0.00191	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	7.47e-05	0.00189	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—GSTT1—type 1 diabetes mellitus	7.12e-05	0.0018	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	6.84e-05	0.00173	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	6.81e-05	0.00173	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	6.23e-05	0.00158	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	6.18e-05	0.00156	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	6.13e-05	0.00155	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—HBA2—type 1 diabetes mellitus	5.6e-05	0.00142	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	5.56e-05	0.00141	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	5.54e-05	0.0014	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	5.53e-05	0.0014	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	5.5e-05	0.00139	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	5.32e-05	0.00135	CbGpPWpGaD
Fluvoxamine—SLC6A3—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	5.29e-05	0.00134	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—G6PC2—type 1 diabetes mellitus	5.26e-05	0.00133	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	5.21e-05	0.00132	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	5.21e-05	0.00132	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	5.06e-05	0.00128	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	4.98e-05	0.00126	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	4.96e-05	0.00126	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	4.96e-05	0.00126	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	4.86e-05	0.00123	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ABCC8—type 1 diabetes mellitus	4.56e-05	0.00116	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	4.37e-05	0.00111	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—HBA2—type 1 diabetes mellitus	4.14e-05	0.00105	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	4.12e-05	0.00104	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—IL6—type 1 diabetes mellitus	4.07e-05	0.00103	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	4.07e-05	0.00103	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—HBA2—type 1 diabetes mellitus	4.06e-05	0.00103	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—HBA2—type 1 diabetes mellitus	4.05e-05	0.00103	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	4.03e-05	0.00102	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—G6PC2—type 1 diabetes mellitus	3.89e-05	0.000986	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—HBA2—type 1 diabetes mellitus	3.82e-05	0.000969	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—G6PC2—type 1 diabetes mellitus	3.81e-05	0.000966	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—G6PC2—type 1 diabetes mellitus	3.81e-05	0.000964	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	3.75e-05	0.000949	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	3.71e-05	0.000941	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—KCNJ11—type 1 diabetes mellitus	3.61e-05	0.000914	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—G6PC2—type 1 diabetes mellitus	3.59e-05	0.000911	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	3.57e-05	0.000906	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	3.55e-05	0.0009	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ABCC8—type 1 diabetes mellitus	3.38e-05	0.000855	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ABCC8—type 1 diabetes mellitus	3.31e-05	0.000838	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	3.3e-05	0.000836	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	3.26e-05	0.000826	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	3.13e-05	0.000793	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ABCC8—type 1 diabetes mellitus	3.12e-05	0.00079	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	3.05e-05	0.000774	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ITPR3—type 1 diabetes mellitus	3.05e-05	0.000772	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	2.94e-05	0.000745	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	2.88e-05	0.000729	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	2.87e-05	0.000728	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—HBA1—type 1 diabetes mellitus	2.87e-05	0.000726	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	2.85e-05	0.000723	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—APOC3—type 1 diabetes mellitus	2.85e-05	0.000722	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GSTT1—type 1 diabetes mellitus	2.8e-05	0.000709	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	2.79e-05	0.000706	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	2.74e-05	0.000693	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	2.71e-05	0.000686	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	2.69e-05	0.000682	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	2.68e-05	0.00068	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—KCNJ11—type 1 diabetes mellitus	2.67e-05	0.000676	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.61e-05	0.000662	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	2.61e-05	0.000661	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	2.55e-05	0.000646	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	2.49e-05	0.000631	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.46e-05	0.000624	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	2.44e-05	0.000618	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	2.35e-05	0.000594	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	2.33e-05	0.000589	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	2.29e-05	0.000581	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ITPR3—type 1 diabetes mellitus	2.25e-05	0.000571	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GCG—type 1 diabetes mellitus	2.23e-05	0.000565	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ITPR3—type 1 diabetes mellitus	2.21e-05	0.000559	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	2.2e-05	0.000558	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—HBA1—type 1 diabetes mellitus	2.12e-05	0.000537	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOC3—type 1 diabetes mellitus	2.11e-05	0.000534	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	2.09e-05	0.000529	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ITPR3—type 1 diabetes mellitus	2.08e-05	0.000527	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—HBA1—type 1 diabetes mellitus	2.08e-05	0.000526	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	2.07e-05	0.000525	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTT1—type 1 diabetes mellitus	2.07e-05	0.000524	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOC3—type 1 diabetes mellitus	2.06e-05	0.000523	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	2.06e-05	0.000522	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTT1—type 1 diabetes mellitus	2.03e-05	0.000513	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	2.02e-05	0.000512	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	2.02e-05	0.000511	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	1.99e-05	0.000504	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	1.99e-05	0.000504	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	1.97e-05	0.000499	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—HBA1—type 1 diabetes mellitus	1.96e-05	0.000496	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOC3—type 1 diabetes mellitus	1.95e-05	0.000493	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTT1—type 1 diabetes mellitus	1.91e-05	0.000484	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CAT—type 1 diabetes mellitus	1.89e-05	0.000478	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	1.88e-05	0.000477	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	1.85e-05	0.00047	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	1.84e-05	0.000466	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	1.77e-05	0.000448	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.76e-05	0.000446	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	1.7e-05	0.000431	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	1.66e-05	0.000421	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GCG—type 1 diabetes mellitus	1.65e-05	0.000418	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GCG—type 1 diabetes mellitus	1.61e-05	0.000409	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	1.61e-05	0.000408	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	1.6e-05	0.000406	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	1.59e-05	0.000403	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	1.57e-05	0.000398	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	1.57e-05	0.000397	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	1.56e-05	0.000396	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	1.56e-05	0.000396	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	1.55e-05	0.000394	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	1.55e-05	0.000393	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	1.53e-05	0.000389	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	1.53e-05	0.000387	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GCG—type 1 diabetes mellitus	1.52e-05	0.000386	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	1.47e-05	0.000373	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	1.46e-05	0.000371	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	1.46e-05	0.00037	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	1.45e-05	0.000368	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.44e-05	0.000365	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	1.44e-05	0.000364	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	1.43e-05	0.000361	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CAT—type 1 diabetes mellitus	1.4e-05	0.000354	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CAT—type 1 diabetes mellitus	1.37e-05	0.000346	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	1.36e-05	0.000346	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.34e-05	0.000339	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	1.33e-05	0.000336	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.31e-05	0.000333	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAT—type 1 diabetes mellitus	1.29e-05	0.000326	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—INS—type 1 diabetes mellitus	1.25e-05	0.000317	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	1.25e-05	0.000316	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	1.25e-05	0.000316	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	1.24e-05	0.000314	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.22e-05	0.000309	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.22e-05	0.000308	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.21e-05	0.000307	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALB—type 1 diabetes mellitus	1.15e-05	0.000291	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.15e-05	0.00029	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.14e-05	0.000288	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.12e-05	0.000284	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	1.1e-05	0.000278	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	1.05e-05	0.000267	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.03e-05	0.000261	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	1.02e-05	0.000259	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	9.71e-06	0.000246	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	9.7e-06	0.000246	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	9.63e-06	0.000244	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	9.61e-06	0.000244	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	9.57e-06	0.000243	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	9.4e-06	0.000238	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	9.26e-06	0.000235	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	9.07e-06	0.00023	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	9.05e-06	0.000229	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—INS—type 1 diabetes mellitus	8.55e-06	0.000217	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	8.49e-06	0.000215	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	8.32e-06	0.000211	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	8.3e-06	0.00021	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	8.22e-06	0.000208	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	8.12e-06	0.000206	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	7.96e-06	0.000202	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	7.94e-06	0.000201	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—type 1 diabetes mellitus	7.84e-06	0.000199	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—type 1 diabetes mellitus	7.5e-06	0.00019	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	7.49e-06	0.00019	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	7e-06	0.000177	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—INS—type 1 diabetes mellitus	6.83e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	6.44e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	6.42e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	6.38e-06	0.000162	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	6.34e-06	0.000161	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	6.26e-06	0.000159	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	6.14e-06	0.000156	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	5.99e-06	0.000152	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	5.9e-06	0.00015	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	5.85e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	5.65e-06	0.000143	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	5.6e-06	0.000142	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	5.45e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	5e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	4.78e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	4.21e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	3.86e-06	9.78e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.69e-06	9.35e-05	CbGpPWpGaD
